Background The healthcare costs of an aging population have major consequences for healthcare organizations and have major implication for strategic planning of services. An impending freeze in budgets in the UK makes these consequences especially significant.
Introduction
There is increasing concern in healthcare organizations throughout the world about how to cope with an aging population. Increases in healthcare costs are strongly associated with increasing age and it is widely projected that the healthcare of the very elderly will account for an increasing proportion of health budgets in the future. 1 -3 In the UK, NHS spending is predicted to be frozen at current levels for at least three subsequent years representing a real terms annual decrease in funding of around 1.6% if current rates of inflation continue. In order to manage future demands and costs commissioning organizations have started to try and estimate the effect that an aging population will have on future costs and how budgetary priorities will have to change.
As part of the NHSs World Class Commissioning process, several primary care trusts (PCTs) have locally presented estimates based on models assuming that the costs of health care in certain age groups will cost the same now as it will in the future (allowing for inflation). However, this type of model ignores two established phenomenon of morbidity compression/expansion 4 and the marked rise in annual healthcare costs in the final years of life, 5 which can account for in the region of 10% of lifetime healthcare costs. 6 Morbidity compression or expansion describes the shortening or lengthening of the period of disability or ill health usually encountered in the years before death. Traditionally people living with ill health require relatively more healthcare expenditure than people in full health. The argument originally posed by Fries 4 suggested that as health and health care improves and life expectancy (LE) increases the period of morbidity prior to death is compressed, i.e. people live longer and have more years in full health than previously. This has subsequently been shown to occur in practice in many several developed countries although not universally. 7 -10 Morbidity compression/expansion can be either relative ( proportion of life spent in ill health) or absolute (number of years spent in ill health). For the purposes of this article we will refer to absolute changes in morbidity since this is more applicable to estimating costs from the data available.
In the UK there is a lack of good quality long-term healthcare cost data based on the age of the individual because of the way the NHS was funded prior to 1997 and availability of robust activity and cost data are still limited in areas other than acute hospital care. This has meant that NHS commissioning organizations have not been able to retrospectively analyze trends in morbidity over a long period of time unlike in some private health insurance schemes, notably in the USA.
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Public health staff in PCTs are often called upon to advise on predictive modeling work both because of their experience in this area and their knowledge of the likely future health trends. This paper describes a methodology that can be easily applied to estimating future healthcare costs using routinely available data that takes into account both increases in costs in the years before death and morbidity compression.
Method
Three models for estimating future healthcare costs are compared. The first applies current age specific healthcare costs published by the Department of Health 12 to the same age group in the future. The second model applies current costs to adjusted future age groups under the assumption that increases in LE result in no compression or expansion of morbidity but that morbidity is postponed to a point later in life equal to the increase in LE. The third applies current costs to adjusted future age groups but also considers the effect of morbidity compression or expansion using a national dataset. In order to optimize clarity the models presented do not include a correction for inflation, although it is strongly recommended that an annual inflation adjustment is included in any model used for service planning.
In order to estimate the future healthcare costs the future population needs to be projected. The Office for National Statistics (ONS), the UK government's statistical service, only provides population projections up to the age of 84 by single year age bands after which all ages are grouped into the 85þ age band. The latest available figures cover the 25 year period from 2006 to 2031. 13 In order to estimate the population in each year age band for those aged 85 and over the probability of dying at any given age were calculated from death rates for England.
14 Several different types of regression line were calculated to assess which achieved the best fit for the relationship between age and probability of death. Goodness of fit was determined by assessing the value of the coefficient of determination R 2 , which could lie between 0 and 1 where a value of 1 indicates that the regression line perfectly fits the data points. An exponential equation best explained this relationship, having the highest coefficient of determination of all the regression analyses (R 2 ¼ 0.98) ( Fig. 1) . This equation was then used to calculate the risk of death of people at each year of age up to the point when the probability of dying in a given year of age reached 1 (age 108). This was then applied to the estimated population in the 85þ age group to estimate numbers in each year age band between age 85 and 108.
All models are applied to the population of the West Midlands region of the UK ( population 5.47 million).
Model 1
The expected annual healthcare costs were derived by calculating the sum of the products of the current average healthcare costs for individual age bands and the number of people in the respective age band for each year, from 2006 to 2031. This is the most basic model tested and inherently results in an expansion of morbidity at the same rate as LE increases and ignores the issue to costs increasing in proximity to death. This is because it implicitly assumes, for example, that the cost of care for an 80 year old in 2006 will be the same as an 80 year at any time in the future. However, in the future an 80 year old is likely to be further away from their age at death, in better health and therefore required less healthcare expenditure than in 2006.
Model 2
For this model we assumed that as LE increases the age at which costs are incurred increased at the same rate. This allows us to take into account the effect that proximity to death has on costs. For example, assuming that the individual lives to the population's LE the cost of treating an 80 year old when the current LE is 80 will be more than treating an 80 year old when the LE is 85 because the proximity to death is 0 and 5 years, respectively. Therefore, applying the current annual healthcare cost of an 80 year old to an 80 year old when the LE is 85 will overestimate future expenditure.
To overcome the above problem we calculated 'health equivalent age bands'. These aim to reflect that a future population with an older LE would have healthcare costs delayed by a period equal to the annual increase in LE, which was on average 0.22 years over the period 1981 -2006 (Table 1) . We assumed that increases in LE have a negligible effect on the healthcare costs of those under the age of 45.
The expected annual healthcare costs were derived by calculating the sum of the products of the current average healthcare costs for individual health equivalent age bands and the number of people in the respective age band for each year, from 2006 to 2031. By applying the costs for health equivalent age bands to the population projections we take account of both the aging population but also the delay in incurring these costs as the average age at death increases.
Model 3
In order to take into account the level of morbidity compression or expansion we considered the ONS figures for both LE and disability-free life expectancy (DFLE) between 1981 and 2006. 15 We hypothesized that if morbidity was delayed by the same amount of time as LE increases then the lines of LE and DFLE would be parallel over time. However, the number of years difference between LE and DFLE showed a slow but consistent increase over time (Fig. 2) .
Over the period 1981 -2006, DFLE increased by 3.64 years whilst LE increased by 5.05 year. By dividing the increase in DFLE by the increase LE we calculated that 0.72 (72%) of LE gained over this period was healthy. This represented morbidity expansion (100% representing no change in the time spent in full health). This figure was then used to modify the health equivalent age bands used in Model 2 by multiplying the annual increase in LE by 0.72 resulting in a slower rate of increase in health equivalent age bands compared with overall LE (Table 1) .
Results
The three models all result in markedly different estimates of future healthcare costs as a result of an aging population (Fig. 3) . The estimated costs predicted by all the models increases year on year compared with the 2006 baseline costs but the rate of increase differs substantially between the models (Table 2 ). Model 1 gives by far the most expensive projections exceeding the expected costs of the next Table 1 Example of health equivalent age bands using annual increase in LE of 0. (Table 3) .
Over the 25 year timeframe of the models, the estimated additional annual healthcare expenditure due to an aging population could be almost doubled if commissioning organizations do not adjust age brackets to reflect their future 'health equivalent' (Table 4) .
Discussion
The increases in healthcare costs in the final years of life and morbidity compression/expansion are so fundamental and have such a large effect on costs the routine use of Models 1 and 2 within the NHS be used with caution. However, Model 3 gives PCTs the ability to realistically predict increases in healthcare expenditure attributable to an aging population whilst taking into account these wellestablished principles. This model can also provide clear figures for the financial consequences of rises or falls in the proportion of disability-free life, which can be used as a strong lever for the preservation or expansion of preventative and rehabilitation services.
These methods can be easily applied to PCT populations using routinely available data. Local adjustments can be made for costs, population growth and changes in LE and DFLE.
We have assumed that the march of human LE will continue unchecked and that there will not come a point in the foreseeable future where humans will reach an age at which further increases in LE is beyond the physiological capacity of the aging body and mind. This so-called rectangularization of the survival curve 16, 17 describes the situation where survival at younger ages becomes increasingly likely and that there is an age at which it becomes physiologically impossible to live beyond. A perfectly rectangular survival curve would be one where no one died until they reached this physiological threshold at which point everyone died. This is in stark contrast to the current survival curves that have a long tail as death occurs at a wide range of ages. The recent 1981-1983 1982-1984 1983-1985 1984-1986 1985-1987 1986-1988 1987-1989 1988-1990 1989-1991 1990-1992 1991-1993 1992-1994 1993-1995 1994-1996 1995-1997 1996-1998 1997-1999 1998- historical trend in LE shows no fall in the annual rate of increase suggesting that the point at which rectangularization is reached (if it exists) is not imminent. As some of the major fatal illnesses become better understood and mortality at younger ages fall so the likelihood of people having to live with conditions that are difficult to delay with interventions increases, e.g. osteoarthritis, Parkinson's disease. 18, 19 The potential for different conditions to compress or expand morbidity varies greatly and the future consequences of modern healthcare are still unpredictable. However, LE and healthy life expectancy (HALE) data from the World Health Organization (WHO) shows that while there appears to be morbidity expansion, i.e. more time spend in ill health, as LE increases up to age 60 it then levels off and starts to decline, i.e. morbidity compression after LE passes 78 (Fig. 4) . 20 This suggests that improvements in economic development and health care initially prolong LE faster than HALE but this difference equalizes and may eventually reverse in countries with the longest LE.
Clearly a compression of morbidity would be desirable in the future both in terms of health and financial benefit. However, treatment of established disease and particularly chronic disease, which is where the majority of many healthcare resources are currently targeted, will only result in a prolongation of unhealthy LE as we keep people with chronic diseases alive for longer. In order to compress morbidity and thus increase healthy LE heavy investment in preventative services is required to help the population maintain health and defer illness to later in life. Reduction of lifestyle risk factors including smoking have been shown to compress morbidity as well as increase LE. 21, 22 The importance of being able to accurately predict demand and costs of health care within the NHS cannot be underestimated. Making over simplistic assumptions and not using well-established principles in these models leads to wildly different outcomes that have the potential to have massive organizational consequences in terms of short-to-medium term strategic planning. The reason for PCTs using over simplistic models is almost certainly unfamiliarity with these principles and lack of appreciation of the effect of aging and morbidity expansion on costs. Public health staff are in an excellent position within PCTs to be able to influence how these models are created and interpreted and to explain these principles to local decisionmakers. Considering these will not only allow better planning but will also help to highlight the need for continued 
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investment in upstream interventions to help as much of the increase in LE to be as healthy as possible. In order to assess the validity of any model it is useful to be able to compare the predicted future trends to historical ones. However, because of the limited availability of the accrual of healthcare costs within the NHS at any given age we consider it almost impossible to be able to make this assessment for these models. This limitation should be considered by healthcare organizations if they choose to explore the use of this methodology in the future.
